Synektik SA

Synektik SA, a midcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its valuation score, reflecting changes in its financial metrics. The company showcases strong profitability with a high Return on Capital Employed and Return on Equity, alongside a favorable PEG ratio and a dividend yield appealing to investors.

Synektik SA, a midcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its valuation score, reflecting its current market position. The company showcases strong financial metrics, including a high Return on Capital Employed and Return on Equity, alongside a favorable PEG ratio and a steady dividend yield.